• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

(1)1.5T 外参照溶液氢质子磁共振波谱成像鉴别乳腺良恶性病变:定性和定量方法的比较。

(1)H MR spectroscopy with external reference solution at 1.5 T for differentiating malignant and benign breast lesions: comparison using qualitative and quantitative approaches.

机构信息

Department of Diagnostic Radiology, International Medical Center of Saitama Medical University, 1397-1 Yamane, Hidaka City, Saitama, Japan.

出版信息

Eur Radiol. 2013 Jan;23(1):75-83. doi: 10.1007/s00330-012-2555-6. Epub 2012 Jul 10.

DOI:10.1007/s00330-012-2555-6
PMID:22777619
Abstract

OBJECTIVE

To compare the diagnostic capability of proton ((1)H) magnetic resonance spectroscopy (MRS) in differentiating benign from malignant breast lesions on the basis of qualitative and quantitative approaches.

METHODS

We performed single-voxel (1)H MRS for 208 breast lesions, identified a clear total composite choline compounds (tCho) peak of signal-to-noise of ≥2 to represent malignancy (qualitative approach), and regarded tCho concentration equal to or greater than the cut-off value to represent malignancy (quantitative approach). We compared the diagnostic ability of both approaches using the Akaike information criterion (AIC) and McFadden's R (2).

RESULTS

Histologically, 169 lesions were malignant; 39 were benign. The qualitative approach demonstrated 84.6 % sensitivity and 51.3 % specificity for differentiating malignant and benign lesions. The mean tCho concentration was 1.13 mmol/kg for malignancy, 0.43 mmol/kg for benignity. The optimal cut-off point was 0.61 mmol/kg, use of which achieved 68.1 % sensitivity and 79.4 % specificity. Calculated AIC and R (2) score suggested the superiority of the quantitative approach for differentiating malignancy.

CONCLUSIONS

Quantitative MRS provides higher specificity than qualitative MRS for differentiating malignant from benign lesions and could be more useful as an additional examination in routine breast MR imaging.

摘要

目的

比较质子((1)H)磁共振波谱(MRS)定性和定量方法在鉴别乳腺良恶性病变中的诊断能力。

方法

对 208 个乳腺病变进行单体素((1)H)MRS 检查,选取信噪比≥2 的清晰总复合胆碱化合物(tCho)峰来代表恶性病变(定性方法),将 tCho 浓度等于或大于截止值来代表恶性病变(定量方法)。使用赤池信息量准则(AIC)和麦克法登 R(2)比较两种方法的诊断能力。

结果

组织学上,169 个病变为恶性,39 个为良性。定性方法鉴别良恶性病变的敏感性为 84.6%,特异性为 51.3%。恶性病变的 tCho 浓度平均值为 1.13mmol/kg,良性病变的 tCho 浓度平均值为 0.43mmol/kg。最佳截断值为 0.61mmol/kg,使用该截断值的敏感性为 68.1%,特异性为 79.4%。计算 AIC 和 R(2)评分表明,定量 MRS 方法在鉴别良恶性病变方面具有更高的特异性。

结论

定量 MRS 比定性 MRS 能更准确地鉴别乳腺良恶性病变,可能作为常规乳腺磁共振成像的附加检查更有用。

相似文献

1
(1)H MR spectroscopy with external reference solution at 1.5 T for differentiating malignant and benign breast lesions: comparison using qualitative and quantitative approaches.(1)1.5T 外参照溶液氢质子磁共振波谱成像鉴别乳腺良恶性病变:定性和定量方法的比较。
Eur Radiol. 2013 Jan;23(1):75-83. doi: 10.1007/s00330-012-2555-6. Epub 2012 Jul 10.
2
Improved diagnostic accuracy in differentiating malignant and benign lesions using single-voxel proton MRS of the breast at 3 T MRI.在 3T MRI 上使用单体素质子 MRS 对乳腺良恶性病变进行鉴别,可提高诊断准确性。
Clin Radiol. 2013 Sep;68(9):e502-10. doi: 10.1016/j.crad.2013.04.002. Epub 2013 May 23.
3
Comparative Investigation of Single Voxel Magnetic Resonance Spectroscopy and Dynamic Contrast Enhancement MR Imaging in Differentiation of Benign and Malignant Breast Lesions in a Sample of Iranian Women.单体素磁共振波谱与动态对比增强磁共振成像在伊朗女性样本中鉴别乳腺良恶性病变的对比研究
Asian Pac J Cancer Prev. 2015;16(18):8335-8. doi: 10.7314/apjcp.2015.16.18.8335.
4
Clinical relevance of total choline (tCho) quantification in suspicious lesions on multiparametric breast MRI.多参数乳腺 MRI 可疑病变中总胆碱(tCho)定量的临床相关性。
Eur Radiol. 2020 Jun;30(6):3371-3382. doi: 10.1007/s00330-020-06678-z. Epub 2020 Feb 17.
5
Application value of 3T ¹H-magnetic resonance spectroscopy in diagnosing breast tumors.3T氢磁共振波谱在乳腺肿瘤诊断中的应用价值
Acta Radiol. 2013 May;54(4):380-8. doi: 10.1177/0284185113475921. Epub 2013 Apr 30.
6
Magnetic resonance spectroscopy of the breast at 3T: pre- and post-contrast evaluation for breast lesion characterization.3T 乳腺磁共振波谱成像:乳腺病变特征的对比剂注射前后评估
ScientificWorldJournal. 2012;2012:754380. doi: 10.1100/2012/754380. Epub 2012 May 3.
7
H-MR spectroscopy of suspicious breast mass lesions at 3T: a clinical experience.3T 下乳腺可疑肿块病变的 H-MR 光谱:临床经验。
Radiol Med. 2017 Mar;122(3):161-170. doi: 10.1007/s11547-016-0713-7. Epub 2016 Dec 15.
8
In vivo proton MR spectroscopy of the breast using the total choline peak integral as a marker of malignancy.利用总胆碱峰积分作为恶性肿瘤标志物的乳腺活体质子磁共振波谱分析。
AJR Am J Roentgenol. 2009 Jun;192(6):1608-17. doi: 10.2214/AJR.07.3521.
9
Diffusion-Weighted Imaging-guided MR Spectroscopy in Breast Lesions using Readout-Segmented Echo-Planar Imaging.使用读出分段回波平面成像的扩散加权成像引导的乳腺病变磁共振波谱分析
Eur Radiol. 2016 Jun;26(6):1565-74. doi: 10.1007/s00330-015-4000-0. Epub 2015 Sep 19.
10
Determination of choline concentration in breast lesions: quantitative multivoxel proton MR spectroscopy as a promising noninvasive assessment tool to exclude benign lesions.测定乳腺病变中的胆碱浓度:定量多体素质子磁共振波谱成像作为一种有前途的无创评估工具,可排除良性病变。
Radiology. 2011 Jun;259(3):695-703. doi: 10.1148/radiol.11101855. Epub 2011 Apr 1.

引用本文的文献

1
In vivo MR spectroscopy for breast cancer diagnosis.用于乳腺癌诊断的活体磁共振波谱分析
BJR Open. 2019 Jul 2;1(1):20180040. doi: 10.1259/bjro.20180040. eCollection 2019.
2
Proton MR spectroscopy in the breast: Technical innovations and clinical applications.质子磁共振波谱在乳腺中的应用:技术创新与临床应用。
J Magn Reson Imaging. 2019 Oct;50(4):1033-1046. doi: 10.1002/jmri.26700. Epub 2019 Mar 7.
3
H-MR spectroscopy of suspicious breast mass lesions at 3T: a clinical experience.3T 下乳腺可疑肿块病变的 H-MR 光谱:临床经验。

本文引用的文献

1
Assessing asthma control in UK primary care: use of routinely collected prospective observational consultation data to determine appropriateness of a variety of control assessment models.评估英国初级保健中的哮喘控制情况:利用常规收集的前瞻性观察性咨询数据,确定各种控制评估模型的适宜性。
BMC Fam Pract. 2011 Sep 29;12:105. doi: 10.1186/1471-2296-12-105.
2
Usefulness of diffusion-weighted imaging of breast tumors: quantitative and visual assessment.弥散加权成像在乳腺肿瘤中的应用:定量和视觉评估。
Jpn J Radiol. 2011 Jul;29(6):429-36. doi: 10.1007/s11604-011-0575-9. Epub 2011 Jul 24.
3
Appropriate timing of proton MR spectroscopy in breast cancer.
Radiol Med. 2017 Mar;122(3):161-170. doi: 10.1007/s11547-016-0713-7. Epub 2016 Dec 15.
4
Diffusion-Weighted Imaging-guided MR Spectroscopy in Breast Lesions using Readout-Segmented Echo-Planar Imaging.使用读出分段回波平面成像的扩散加权成像引导的乳腺病变磁共振波谱分析
Eur Radiol. 2016 Jun;26(6):1565-74. doi: 10.1007/s00330-015-4000-0. Epub 2015 Sep 19.
5
1H-MRS evaluation of breast lesions by using total choline signal-to-noise ratio as an indicator of malignancy: a meta-analysis.以总胆碱信噪比为恶性肿瘤指标的乳腺病变1H-MRS评估:一项荟萃分析。
Med Oncol. 2015 May;32(5):160. doi: 10.1007/s12032-015-0603-1. Epub 2015 Apr 21.
6
In vivo post-contrast 1H-MRS evaluation of malignant and benign breast lesions: a meta-analysis.体内对比剂增强后 1H-MRS 对乳腺良恶性病变的评估:一项荟萃分析
Tumour Biol. 2015 Jan;36(1):345-52. doi: 10.1007/s13277-014-2635-0. Epub 2014 Sep 27.
7
Optical imaging for monitoring tumor oxygenation response after initiation of single-agent bevacizumab followed by cytotoxic chemotherapy in breast cancer patients.单药贝伐珠单抗治疗后联合细胞毒化疗监测乳腺癌患者肿瘤氧合反应的光学成像。
PLoS One. 2014 Jun 6;9(6):e98715. doi: 10.1371/journal.pone.0098715. eCollection 2014.
8
Influence of calcium on choline measurements by 1H MR spectroscopy of thigh muscles.钙对大腿肌肉 1HMR 光谱胆碱测量的影响。
Eur Radiol. 2014 Jun;24(6):1309-19. doi: 10.1007/s00330-014-3131-z. Epub 2014 Mar 16.
9
Differential diagnosis between malignant and benign breast lesions using single-voxel proton MRS: a meta-analysis.使用单体素质子 MRS 对良恶性乳腺病变进行鉴别诊断:一项荟萃分析。
J Cancer Res Clin Oncol. 2014 Jun;140(6):993-1001. doi: 10.1007/s00432-014-1605-7. Epub 2014 Mar 6.
乳腺癌质子磁共振波谱的适时检测。
Magn Reson Med Sci. 2011;10(2):71-7. doi: 10.2463/mrms.10.71.
4
Comparison of qualitative and quantitative approach to prostate MR spectroscopy in peripheral zone cancer detection.定性与定量方法检测外周带前列腺癌的磁共振波谱分析比较。
Eur J Radiol. 2012 Mar;81(3):411-6. doi: 10.1016/j.ejrad.2010.12.017. Epub 2011 Jan 6.
5
Diagnostic performance of ADC for Non-mass-like breast lesions on MR imaging.MR 成像中非肿块样乳腺病变 ADC 值的诊断性能。
Magn Reson Med Sci. 2010;9(4):217-25. doi: 10.2463/mrms.9.217.
6
Background parenchymal enhancement on baseline screening breast MRI: impact on biopsy rate and short-interval follow-up.基线筛查乳腺 MRI 上的背景实质增强:对活检率和短期随访的影响。
AJR Am J Roentgenol. 2011 Jan;196(1):218-24. doi: 10.2214/AJR.10.4550.
7
Clinical characteristics and biomarkers of breast cancer associated with choline concentration measured by 1H MRS.1H MRS 测量胆碱浓度与乳腺癌相关的临床特征和生物标志物。
NMR Biomed. 2011 Apr;24(3):316-24. doi: 10.1002/nbm.1595. Epub 2010 Sep 22.
8
Role of magnetic resonance imaging in evaluating the extent of disease.
Magn Reson Imaging Clin N Am. 2010 May;18(2):199-206, vii-viii. doi: 10.1016/j.mric.2010.02.002.
9
1H MR spectroscopy of invasive ductal carcinoma: correlations with FDG PET and histologic prognostic factors.1H 磁共振波谱分析浸润性导管癌:与 FDG PET 及组织学预后因素的相关性。
AJR Am J Roentgenol. 2010 May;194(5):1384-90. doi: 10.2214/AJR.09.3431.
10
Predicting pathological response to neoadjuvant chemotherapy in breast cancer with quantitative 1H MR spectroscopy using the external standard method.采用外标法的 1H MR 波谱定量分析预测乳腺癌新辅助化疗的病理反应。
J Magn Reson Imaging. 2010 Apr;31(4):895-902. doi: 10.1002/jmri.22118.